Evaluation of safety and clinical activity of multiple doses of the anti-CD80 monoclonal antibody, galiximab, in patients with moderate to severe plaque psoriasis

Alice B. Gottlieb, Sewon Kang, Kenneth G. Linden, Mark Lebwohl, Alan Menter, Ahsan A. Abdulghani, Michael Goldfarb, Nicole Chieffo, Mark C. Totoritis

Research output: Contribution to journalArticlepeer-review

42 Scopus citations

Fingerprint

Dive into the research topics of 'Evaluation of safety and clinical activity of multiple doses of the anti-CD80 monoclonal antibody, galiximab, in patients with moderate to severe plaque psoriasis'. Together they form a unique fingerprint.

Medicine & Life Sciences